Search

Search Constraints

You searched for: Author/Creator LLarch, Neus

Search Results

1. Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials. (25th July 2020)

2. Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. Issue 6 (6th July 2021)

3. Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. Issue 6 (6th July 2021)

4. Systematic review with meta‐analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib. Issue 5 (29th January 2019)

5. Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second‐line trial design. Issue 6 (29th October 2013)